1324010-46-9

Upstream product

• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 22744-12-3 [4-(methoxycarbonyl)phenyl]acetic acid 
• 142667-04-7 4-chlorocarbonylmethyl-benzoic acid methyl ester 
• 1324010-44-7 methyl 4-(2-(2,4-dimethoxyphenyl)-2-oxoethyl)benzoate 
• 1324010-45-8 ethyl 4-(2-(2,4-dihydroxyphenyl)-2-oxoethyl)benzoate 

Downstream Products

• 1324010-45-8 ethyl 4-(2-(2,4-dihydroxyphenyl)-2-oxoethyl)benzoate 
• 1324052-34-7 ethyl 4-(2-(difluoromethyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)benzoate 
• 1324052-33-6 4-(2-(difluoromethyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)benzoic acid 
• 1324010-12-9 3-(4-(7-hydroxy-4-oxo-2-(trifluoromethyl)-4H-chromen-3-yl)phenyl)-1,2,4-oxadiazol-5(4H)-one 
• 1324010-14-1 3-(4-(7-hydroxy-4-oxo-2-(trifluoromethyl)-4H-chromen-3-yl)phenyl)-1,2,4-thiadiazol-5(4H)-one 
• 1324009-96-2 3-(4-(1H-tetrazol-5-yl)phenyl)-7-hydroxy-2-(trifluoromethyl)-4H-chromen-4-one 
• 1324009-97-3 4-(7-hydroxy-4-oxo-2-(trifluoromethyl)-4H-chromen-3-yl)benzonitrile 

Relevant academic research and scientific papers

CHROMONE INHIBITORS OF S-NITROSOGLUTATHIONE REDUCTASE

The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

NOVEL S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.